Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 22, no: 6 |
NetGPI | no | yes: 0, no: 28 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0009986 | cell surface | 2 | 1 |
Related structures:
AlphaFold database: E9B231
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 29 |
GO:0006259 | DNA metabolic process | 4 | 29 |
GO:0006308 | DNA catabolic process | 5 | 29 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 29 |
GO:0006807 | nitrogen compound metabolic process | 2 | 29 |
GO:0008152 | metabolic process | 1 | 29 |
GO:0009056 | catabolic process | 2 | 29 |
GO:0009057 | macromolecule catabolic process | 4 | 29 |
GO:0009987 | cellular process | 1 | 29 |
GO:0019439 | aromatic compound catabolic process | 4 | 29 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 29 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 29 |
GO:0043170 | macromolecule metabolic process | 3 | 29 |
GO:0044237 | cellular metabolic process | 2 | 29 |
GO:0044238 | primary metabolic process | 2 | 29 |
GO:0044248 | cellular catabolic process | 3 | 29 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 29 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 29 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 29 |
GO:0046483 | heterocycle metabolic process | 3 | 29 |
GO:0046700 | heterocycle catabolic process | 4 | 29 |
GO:0071704 | organic substance metabolic process | 2 | 29 |
GO:0090304 | nucleic acid metabolic process | 4 | 29 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 29 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 29 |
GO:1901575 | organic substance catabolic process | 3 | 29 |
GO:0006163 | purine nucleotide metabolic process | 5 | 1 |
GO:0006195 | purine nucleotide catabolic process | 6 | 1 |
GO:0006196 | AMP catabolic process | 7 | 1 |
GO:0006753 | nucleoside phosphate metabolic process | 4 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0009117 | nucleotide metabolic process | 5 | 1 |
GO:0009123 | nucleoside monophosphate metabolic process | 5 | 1 |
GO:0009125 | nucleoside monophosphate catabolic process | 6 | 1 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 6 | 1 |
GO:0009128 | purine nucleoside monophosphate catabolic process | 7 | 1 |
GO:0009150 | purine ribonucleotide metabolic process | 6 | 1 |
GO:0009154 | purine ribonucleotide catabolic process | 6 | 1 |
GO:0009158 | ribonucleoside monophosphate catabolic process | 7 | 1 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 6 | 1 |
GO:0009166 | nucleotide catabolic process | 6 | 1 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 7 | 1 |
GO:0009169 | purine ribonucleoside monophosphate catabolic process | 8 | 1 |
GO:0009259 | ribonucleotide metabolic process | 5 | 1 |
GO:0009261 | ribonucleotide catabolic process | 5 | 1 |
GO:0019637 | organophosphate metabolic process | 3 | 1 |
GO:0019693 | ribose phosphate metabolic process | 4 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0046033 | AMP metabolic process | 7 | 1 |
GO:0046434 | organophosphate catabolic process | 4 | 1 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 1 |
GO:0072521 | purine-containing compound metabolic process | 4 | 1 |
GO:0072523 | purine-containing compound catabolic process | 5 | 1 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 1 |
GO:1901136 | carbohydrate derivative catabolic process | 4 | 1 |
GO:1901292 | nucleoside phosphate catabolic process | 5 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 29 |
GO:0003824 | catalytic activity | 1 | 29 |
GO:0004518 | nuclease activity | 4 | 29 |
GO:0004519 | endonuclease activity | 5 | 29 |
GO:0005488 | binding | 1 | 29 |
GO:0016787 | hydrolase activity | 2 | 29 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 29 |
GO:0043167 | ion binding | 2 | 29 |
GO:0043169 | cation binding | 3 | 29 |
GO:0046872 | metal ion binding | 4 | 29 |
GO:0097159 | organic cyclic compound binding | 2 | 29 |
GO:1901363 | heterocyclic compound binding | 2 | 29 |
GO:0008252 | nucleotidase activity | 6 | 1 |
GO:0008254 | 3'-nucleotidase activity | 7 | 1 |
GO:0016791 | phosphatase activity | 5 | 1 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 366 | 368 | PF00082 | 0.511 |
CLV_PCSK_KEX2_1 | 40 | 42 | PF00082 | 0.443 |
CLV_PCSK_PC1ET2_1 | 366 | 368 | PF00082 | 0.493 |
CLV_PCSK_PC1ET2_1 | 40 | 42 | PF00082 | 0.459 |
CLV_PCSK_SKI1_1 | 185 | 189 | PF00082 | 0.542 |
CLV_PCSK_SKI1_1 | 272 | 276 | PF00082 | 0.475 |
CLV_PCSK_SKI1_1 | 280 | 284 | PF00082 | 0.424 |
CLV_PCSK_SKI1_1 | 288 | 292 | PF00082 | 0.447 |
DOC_CKS1_1 | 94 | 99 | PF01111 | 0.263 |
DOC_CYCLIN_RxL_1 | 50 | 61 | PF00134 | 0.206 |
DOC_CYCLIN_yCln2_LP_2 | 238 | 244 | PF00134 | 0.152 |
DOC_MAPK_gen_1 | 3 | 12 | PF00069 | 0.411 |
DOC_MAPK_MEF2A_6 | 3 | 11 | PF00069 | 0.472 |
DOC_MAPK_MEF2A_6 | 30 | 37 | PF00069 | 0.357 |
DOC_USP7_UBL2_3 | 271 | 275 | PF12436 | 0.291 |
DOC_WW_Pin1_4 | 106 | 111 | PF00397 | 0.280 |
DOC_WW_Pin1_4 | 64 | 69 | PF00397 | 0.314 |
DOC_WW_Pin1_4 | 93 | 98 | PF00397 | 0.266 |
LIG_Actin_WH2_2 | 285 | 300 | PF00022 | 0.234 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.515 |
LIG_BIR_III_3 | 1 | 5 | PF00653 | 0.416 |
LIG_EH1_1 | 345 | 353 | PF00400 | 0.259 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.349 |
LIG_FHA_1 | 111 | 117 | PF00498 | 0.314 |
LIG_FHA_1 | 182 | 188 | PF00498 | 0.295 |
LIG_FHA_1 | 246 | 252 | PF00498 | 0.286 |
LIG_FHA_1 | 300 | 306 | PF00498 | 0.227 |
LIG_FHA_1 | 336 | 342 | PF00498 | 0.349 |
LIG_FHA_1 | 352 | 358 | PF00498 | 0.330 |
LIG_FHA_2 | 123 | 129 | PF00498 | 0.256 |
LIG_FHA_2 | 228 | 234 | PF00498 | 0.356 |
LIG_FHA_2 | 263 | 269 | PF00498 | 0.347 |
LIG_GBD_Chelix_1 | 137 | 145 | PF00786 | 0.391 |
LIG_GBD_Chelix_1 | 289 | 297 | PF00786 | 0.487 |
LIG_GBD_Chelix_1 | 347 | 355 | PF00786 | 0.199 |
LIG_GBD_Chelix_1 | 356 | 364 | PF00786 | 0.345 |
LIG_IRF3_LxIS_1 | 104 | 109 | PF10401 | 0.154 |
LIG_LIR_Gen_1 | 212 | 220 | PF02991 | 0.284 |
LIG_LIR_Gen_1 | 89 | 99 | PF02991 | 0.315 |
LIG_LIR_LC3C_4 | 354 | 357 | PF02991 | 0.210 |
LIG_LIR_Nem_3 | 212 | 216 | PF02991 | 0.284 |
LIG_LIR_Nem_3 | 323 | 328 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 368 | 373 | PF02991 | 0.549 |
LIG_LIR_Nem_3 | 89 | 94 | PF02991 | 0.322 |
LIG_NRBOX | 140 | 146 | PF00104 | 0.191 |
LIG_NRBOX | 6 | 12 | PF00104 | 0.558 |
LIG_PDZ_Class_2 | 373 | 378 | PF00595 | 0.583 |
LIG_SH2_NCK_1 | 373 | 377 | PF00017 | 0.536 |
LIG_SH2_SRC | 222 | 225 | PF00017 | 0.234 |
LIG_SH2_SRC | 373 | 376 | PF00017 | 0.556 |
LIG_SH2_STAT5 | 222 | 225 | PF00017 | 0.300 |
LIG_SH2_STAT5 | 363 | 366 | PF00017 | 0.682 |
LIG_SH2_STAT5 | 93 | 96 | PF00017 | 0.238 |
LIG_SH3_3 | 201 | 207 | PF00018 | 0.257 |
LIG_SH3_3 | 62 | 68 | PF00018 | 0.252 |
LIG_SH3_3 | 94 | 100 | PF00018 | 0.269 |
LIG_SUMO_SIM_anti_2 | 139 | 145 | PF11976 | 0.203 |
LIG_SUMO_SIM_anti_2 | 34 | 39 | PF11976 | 0.321 |
LIG_SUMO_SIM_anti_2 | 354 | 360 | PF11976 | 0.224 |
LIG_SUMO_SIM_par_1 | 10 | 15 | PF11976 | 0.528 |
LIG_SUMO_SIM_par_1 | 104 | 109 | PF11976 | 0.354 |
LIG_SUMO_SIM_par_1 | 56 | 61 | PF11976 | 0.291 |
LIG_TYR_ITIM | 371 | 376 | PF00017 | 0.516 |
LIG_UBA3_1 | 305 | 310 | PF00899 | 0.233 |
LIG_Vh1_VBS_1 | 340 | 358 | PF01044 | 0.185 |
MOD_CK1_1 | 181 | 187 | PF00069 | 0.392 |
MOD_CK1_1 | 245 | 251 | PF00069 | 0.184 |
MOD_CK2_1 | 122 | 128 | PF00069 | 0.233 |
MOD_CK2_1 | 191 | 197 | PF00069 | 0.347 |
MOD_CK2_1 | 229 | 235 | PF00069 | 0.317 |
MOD_CK2_1 | 43 | 49 | PF00069 | 0.322 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.630 |
MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.440 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.258 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.505 |
MOD_GSK3_1 | 223 | 230 | PF00069 | 0.262 |
MOD_GSK3_1 | 311 | 318 | PF00069 | 0.440 |
MOD_GSK3_1 | 331 | 338 | PF00069 | 0.455 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.217 |
MOD_N-GLC_1 | 102 | 107 | PF02516 | 0.481 |
MOD_N-GLC_1 | 293 | 298 | PF02516 | 0.565 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.329 |
MOD_NEK2_1 | 223 | 228 | PF00069 | 0.288 |
MOD_NEK2_1 | 293 | 298 | PF00069 | 0.282 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.317 |
MOD_NEK2_1 | 58 | 63 | PF00069 | 0.246 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.266 |
MOD_PKA_1 | 275 | 281 | PF00069 | 0.290 |
MOD_Plk_1 | 102 | 108 | PF00069 | 0.257 |
MOD_Plk_1 | 223 | 229 | PF00069 | 0.272 |
MOD_Plk_1 | 245 | 251 | PF00069 | 0.292 |
MOD_Plk_1 | 293 | 299 | PF00069 | 0.335 |
MOD_Plk_2-3 | 102 | 108 | PF00069 | 0.304 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.254 |
MOD_Plk_4 | 12 | 18 | PF00069 | 0.469 |
MOD_Plk_4 | 351 | 357 | PF00069 | 0.245 |
MOD_Plk_4 | 43 | 49 | PF00069 | 0.302 |
MOD_ProDKin_1 | 106 | 112 | PF00069 | 0.280 |
MOD_ProDKin_1 | 64 | 70 | PF00069 | 0.314 |
MOD_ProDKin_1 | 93 | 99 | PF00069 | 0.266 |
MOD_SUMO_rev_2 | 193 | 200 | PF00179 | 0.296 |
MOD_SUMO_rev_2 | 314 | 322 | PF00179 | 0.351 |
MOD_SUMO_rev_2 | 323 | 333 | PF00179 | 0.344 |
MOD_SUMO_rev_2 | 75 | 83 | PF00179 | 0.270 |
TRG_DiLeu_BaEn_1 | 139 | 144 | PF01217 | 0.152 |
TRG_DiLeu_BaEn_1 | 279 | 284 | PF01217 | 0.234 |
TRG_DiLeu_BaEn_4 | 246 | 252 | PF01217 | 0.152 |
TRG_ENDOCYTIC_2 | 213 | 216 | PF00928 | 0.274 |
TRG_ENDOCYTIC_2 | 373 | 376 | PF00928 | 0.690 |
TRG_ER_diArg_1 | 3 | 6 | PF00400 | 0.397 |
TRG_NES_CRM1_1 | 150 | 164 | PF08389 | 0.305 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I8Q7 | Leptomonas seymouri | 35% | 100% |
A0A0S4JAL3 | Bodo saltans | 41% | 100% |
A0A1X0P2K7 | Trypanosomatidae | 45% | 100% |
A0A3Q8IBF6 | Leishmania donovani | 45% | 99% |
A0A3Q8IEW3 | Leishmania donovani | 38% | 100% |
A0A3Q8IFH4 | Leishmania donovani | 88% | 100% |
A0A3Q8IK90 | Leishmania donovani | 62% | 100% |
A0A3S7X3A6 | Leishmania donovani | 39% | 100% |
A0A422N7B0 | Trypanosoma rangeli | 42% | 100% |
A4H6V5 | Leishmania braziliensis | 46% | 100% |
A4HI96 | Leishmania braziliensis | 35% | 100% |
A4HJL3 | Leishmania braziliensis | 73% | 100% |
A4I5I0 | Leishmania infantum | 38% | 100% |
A4I736 | Leishmania infantum | 88% | 100% |
C9ZQH5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
C9ZQH6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
C9ZQW0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
E9AGC7 | Leishmania infantum | 45% | 99% |
E9ANW7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 46% | 100% |
E9B0S4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 38% | 100% |
E9B0S5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 38% | 100% |
F4JJL0 | Arabidopsis thaliana | 29% | 100% |
F4JJL3 | Arabidopsis thaliana | 27% | 100% |
P24021 | Aspergillus oryzae (strain ATCC 42149 / RIB 40) | 26% | 100% |
Q4Q630 | Leishmania major | 88% | 100% |
Q4Q7F3 | Leishmania major | 38% | 100% |
Q4Q7F4 | Leishmania major | 39% | 100% |
Q4QGQ3 | Leishmania major | 44% | 100% |
Q66VY6 | Leishmania major | 64% | 100% |
Q8LDW6 | Arabidopsis thaliana | 27% | 100% |
Q9C9G4 | Arabidopsis thaliana | 28% | 100% |
Q9SXA6 | Arabidopsis thaliana | 30% | 100% |
V5B8Z9 | Trypanosoma cruzi | 40% | 97% |